Navigation Links
FDA approves MyocondaR IND for MAP in Crohn's Disease

at which will now be an all-in-one oral capsule, the increased dosages and the new indication being sought.

"We are very pleased to have reached this key milestone in the development of MyocondaR. There is clearly a need for this type of therapy for the substantial subset of Crohn's Disease patients infected with MAP who are not well served by current therapies," said Patrick McLean, CEO of Giaconda "Giaconda is now another step closer to achieving its aim of bringing this product to market as soon as possible for the benefit of patients who are infected with MAP.

The development of MyocondaR is supported by a significant number of opinion leaders in the field". About Giaconda Limited Giaconda Limited is a biotechnology company involved in developing and licensing innovative and cost effective medical therapies in the field of gastroenterology. Giaconda's products are targeted towards the treatment of serious conditions that are not adequately addressed by any existing therapy. In this way, Giaconda's products are intended to satisfy these significant unmet medical needs of the gastrointestinal market. The Giaconda portfolio consists of five products, all of which are novel combinations of known compounds. Giaconda has two lead products, MyocondaR for the treatment of Crohn's Disease and HelicondaR for the treatment of resistant Helicobacter pylori infection. For more information please visit www.giacondalimited.com

About MyocondaR -
A Combination Antibiotic Therapy for the Treatment of Crohn's Disease MyocondaR, the Company's Anti-MAP therapy for the treatment of Crohn's Disease is a combination of three registered anti-mycobacterial drugs - rifabutin, clarithromycin and clofazimine. These three drugs are widely marketed world-wide for the treatment of mycobacterial and other infections. MyocondaR presents these three compounds in a specific patented combin
'"/>




Page: 1 2 3 4

Related medicine technology :

1. FDA approves IND on Lead Product M6G
2. ChemoCentryx Presents Positive Phase 2 Clinical Data for Traficet-EN in Crohns Disease at the Digestive Disease Week 2007 Conference
3. Enzo Biochem Individualized Oral Immune Regulation Therapy May Be Effective Approach to Treating Crohns Disease
4. UCB Presents Long-Term CImzia Data in Crohns Disease
5. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
6. Appendicitis: Evolving Tools to Diagnose a Classic Disease
7. Non-Invasive Diagnostic Tests for Celiac Disease
8. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
11. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FDA approves MyocondaR IND for MAP Crohn Disease
(Date:7/22/2014)... 2014 Elekta (NSE:EKTAb) and Royal Philips ... NHS Foundation Trust ( Manchester, UK ), ... mission is to develop the clinical value of an ... Such a system would, in principle, improve the practice ... "The Christie was an essential participant in ...
(Date:7/22/2014)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... of patients in its ongoing Phase 2 trial (Study ... the revised clinical protocol agreed to with the FDA ... Halozyme,s proprietary recombinant human hyaluronidase under development for the ... "Our diligent effort to rapidly re-initiate patient enrollment ...
(Date:7/22/2014)... July 22, 2014  Neurotrope Bioscience, Inc., a subsidiary ... exclusive license agreement with the Icahn School of Medicine ... Mount Sinai ) to utilize its proprietary information ... the treatment of Niemann-Pick Type C Disease (NPC), a ... Alzheimer-like symptoms. The license also covers other diseases and ...
Breaking Medicine Technology:The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5
... DATATRAK International, Inc. (OTCQX: DATA), a technology and services ... trials industry, today announced that it has been awarded ... Organization (CRO) in India, with which the Company had ... order to execute a Phase II study for the ...
... 8, 2011 Vanda Pharmaceuticals Inc. (Nasdaq: ... has granted orphan drug designation for tasimelteon, an oral ... for Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals with ... the designation that the Committee for Orphan Medicinal Products ...
Cached Medicine Technology:DATATRAK Awarded First Study With Kreara Solutions 2DATATRAK Awarded First Study With Kreara Solutions 3Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 2Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 3Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 4
(Date:7/22/2014)... the University of Murcia have studied the changes ... a personality trait that causes difficulties in inhibiting ... and leads to unplanned actions without considering the ... indicator for predicting the risk of behavioural problems. ... the University of Murcia analyses whether the connectivity ...
(Date:7/22/2014)... CyraCom has been ranked as North ... translation and interpreting industry. Released June 2014 by the ... "The Language Services Market: 2014," also ranked CyraCom as ... up two spots from 2013. , In 2013, Common ... provide interpretation services – a subset of the language ...
(Date:7/22/2014)... 2014 The Muscular Dystrophy Association (MDA) and ... MUSCLE UP campaign that will raise funds to ... million Americans fighting muscle disease. , As part ... Jiffy Lube service centers through Sept. 1, 2014 to make ... make progress in the fight for muscle health. Since 2012, ...
(Date:7/22/2014)... The Restful Jaw Company announces its latest ... ®. The FDA-registered external device is clinically proven to ... fatigue and soreness during dental procedures. As such, patients ... do not need to take breaks or terminate procedures ... a vital solution in helping more than 31 million ...
(Date:7/22/2014)... Alan Mozes HealthDay Reporter ... drug already used to treat moderate-to-severe allergic asthma appears to ... helped by standard medications, new research suggests. The prescription ... hives, following U.S. Food and Drug Administration approval earlier this ... when Xolair is taken at a high dose for a ...
Breaking Medicine News(10 mins):Health News:Children's impulsive behaviour is related to their brain connectivity 2Health News:CyraCom Ranked Among the World’s Largest Language Service Providers 2Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 2Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 3Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 2Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 3Health News:Asthma Drug May Help Those With Chronic Hives 2Health News:Asthma Drug May Help Those With Chronic Hives 3
... Indian Railways handed over the new five state-of-the-art coach ... train, to Impact India Foundation here today. Speaking on ... said that since 1991, Impact India Foundation with the ... of cost to nearly 4,50,000 persons in remote and ...
... McCartney is pregnant again, just 7 months after giving birth to ... expecting her third child with husband Alasdhair Willis before the end ... legend dad Sir Paul McCartney is thrilled after hearing the news. ... has been getting him through the tough times. He would be ...
... tobacco industrys deceptive practices have been aggressively quashed through ... Ibrahim , co-author of an analysis in the August ... ,In the article, Ibrahim tracks the rise and ... for the past 40 years. She chronicles industry strategies ...
... structure of a key molecule called 'P2X receptor' that ... might lead to the development of painkillers for recurring ... by a team of researchers including Dr Chris Thompson, ... University of Manchester. ,Researchers examined slime moulds, ...
... the capacity of short-term memory is a strong predictor of ... ,A study conducted by them has shown that an ... time, but people with high IQ levels can remember more ... Vogel of the university conducted laboratory experiments to test their ...
... without fear of prosecution in one English city's pubs ... national ban, the local council admitted Wednesday . ... can spark up knowing that bureaucrats cannot impose the ... to get enforcement powers in time for July 1, ...
Cached Medicine News:Health News:New Lifeline Express Train Inaugurated 2Health News:Tobacco Industry Promotes Antismoking Campaigns 2Health News:Tobacco Industry Promotes Antismoking Campaigns 3Health News:Blunder Leaves Smoking Ban Up in Smoke in Stoke 2
Provides effective stretching of the plantar fascia and Achilles Tendon with bi-lateral dorsiflexion assist straps that allow the patient to adjust the degree of flexion to their individual requireme...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... to treat Achilles tendonitis and plantar fasciitis. Using ... and in back of the heel, the AirHeel ... reduce swelling and enhance circulation. The AirHeel is ... to apply just slip it on like ...
... of controlled compression and cold, the Foot ... anatomically designed cuff provides complete foot coverage ... as a single cuff, or with a ... disk). The Cooler is available separately and ...
Medicine Products: